Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice

Cancer Research

Volumn 66, Issue 15, 2006, Pages 7395-7400

  Rao, Varada P ^a   Poutahidis, Theofilos ^a,d   Ge, Zhongming ^a   Nambiar, Prashant R ^a   Boussahmain, Chakib ^a   Wang, Yan Yan ^b,c   Horwitz, Bruce H ^b,c   Fox, James G ^a   Erdman, Susan E ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; RAG2 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADENOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CANCER THERAPY; CARCINOGENESIS; CD25+ T LYMPHOCYTE; COLON CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENTEROBACTERIACEAE; FEMALE; HELICOBACTER HEPATICUS; HYGIENE; INFLAMMATION; INNATE IMMUNITY; INTESTINE CARCINOMA; INTESTINE TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; UPREGULATION;

ADENOCARCINOMA; ANIMALS; DNA-BINDING PROTEINS; FEMALE; HELICOBACTER HEPATICUS; HELICOBACTER INFECTIONS; IMMUNITY, NATURAL; IMMUNOGLOBULINS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-10; INTESTINAL NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; RECEPTORS, INTERLEUKIN-2; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33747481384     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-0558     Document Type: Article

References (34)

1. Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology (Williston Park) 2002;16:217-26, 29; discussion 30-2.
2. O'Byrne KJ, Dalgleish AG. Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer 2001;85:473-83.
3. Badawi AF, Mostafa MH, Probert A, O'Connor PJ. Role of schistosomiasis in human bladder cancer: evidence of association, aetiological factors, and basic mechanisms of carcinogenesis. Eur J Cancer Prev 1995;4:45-59.
4. Imperial JC. Natural history of chronic hepatitis B and C. J Gastroenterol Hepatol 1999;14 Suppl:S1-5.
5. Blaser MJ. Linking Helicobacter pylori to gastric cancer. Nat Med 2000;6:376-7.
6. Rhodes JM, Campbell BJ. Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol Med 2002;8:10-6.
7. Malkinson AM, Bauer A, Meyer A, et al. Experimental evidence from an animal model of adenocarcinoma that chronic inflammation enhances lung cancer risk Chest 2000;117:228S.
8. McCann J. Esophageal cancers: changing character, increasing incidence. J Natl Cancer Inst 1999;91:497-8.
9. ACS cancer facts and figures 2004. US Cancer Fact and Figures; 2004.
10. Fodde R, Kuipers J, Rosenberg C, et al. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 2001;3:433-8.
11. Furuuchi K, Tada M, Yamada H, et al. Somatic mutations of the APC gene in primary breast cancers. Am J Pathol 2000;156:1997-2005.
12. van Es JH, Giles RH, Clevers HC The many faces of the tumor suppressor gene APC. Exp Cell Res 2001;264:126-34.
13. Moser AR, Luongo C, Gould KA, McNeley MK. Shoemaker AR, Dove WF. ApcMin: a mouse model for intestinal and mammary tumorigenesis. Eur J Cancer 1995;31A:1061-4.
14. Erdman SE, Sohn JJ, Rao VP, et al. CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice. Cancer Res 2005;65:3998-4004.
15. Rao VP, Poutahidis T, Ge Z, et al. Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice. Cancer Res 2006;66:57-61.
16. Moser AR, Mattes EM, Dove WF, Lindstrom MJ, Haag JD, Gould MN. ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc Natl Acad Sci U S A 1993;90:8977-81.
17. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 1994;179:589-600.
18. Ge Z, Feng Y, Whary MT, et al. Cytolethal distending toxin is essential for Helicobacter hepaticus colonization in outbred Swiss Webster mice. Infect Immun 2005;73:3559-67.
19. Fox JG, Dewhirst FE, Tully JG, et al. Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J Clin Microbiol 1994;32:1238-45.
20. Erdman SE, Poutahidis T, Tomczak M, et al. CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol 2003;162:691-702.
21. Mihara M. Tan I, Chuzhin Y, et al. CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus. J Clin Invest 2000;106:91-101.
22. Erdman SE, Rao VP, Poutahidis T, et al. CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res 2003;63:6042-50.
23. Lewis CE, Leek R, Harris A, McGee JO. Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leukoc Biol 1995;57:747-51.
24. Leek RD, Harris AL. Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia 2002;7:177-89.
25. Miyoshi K, Rosner A, Nozawa M, et al. Activation of different Wnt/β-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Oncogene 2002;21:5548-56.
26. Coletta PL, Muller AM, Jones EA, et al. Lymphodepletion in the ApcMin/+ mouse model of intestinal tumorigenesis. Blood 2004;103:1050-8.
27. + T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003;197:111-9.
28. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
29. Coombes JL, Robinson NJ, Maloy KJ, Uhlig HH, Powrie F. Regulatory T cells and intestinal homeostasis. Immunol Rev 2005;204:184-94.
30. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol 2005;6:353-60.
31. Kullberg MC, Jankovic D, Gorelick PL, et al. Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med 2002;196:505-15.
32. Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-β-bearing regulatory cells. J Immunol 2005;174:3237-46.
33. Wilson MS, Taylor MD, Balic A, Finney CA, Lamb JR, Maizels RM. Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med 2005;202:1199-212.
34. Mocellin S, Marincola FM, Young HA. Interleukin-10 and the immune response against cancer: a counter-point J Leukoc Biol 2005;78:1043-51.